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Objective: We assessed the impact on histologic and behavioral outcome of
an interval of retrograde cerebral perfusion after arterial embolization,
comparing retrograde cerebral perfusion with and without inferior vena
caval occlusion with continued antegrade perfusion. Methods: Sixty York-
shire pigs (27 to 30 kg) were randomly assigned to the following groups:
antegrade cerebral perfusion control; antegrade cerebral perfusion after
embolization; retrograde cerebral perfusion control; retrograde cerebral
perfusion after embolization; retrograde cerebral perfusion with inferior
vena cava occlusion, retrograde cerebral perfusion with inferior vena cava
occlusion control, and retrograde cerebral perfusion with inferior vena cava
occlusion after embolization. After cooling to 20° C, a bolus of 200 mg of
polystyrene microspheres 250 to 750 (mm diameter (or saline solution) was
injected into the isolated aortic arch. After 5 minutes of antegrade cerebral
perfusion, 25 minutes of antegrade cerebral perfusion, retrograde cerebral
perfusion, or retrograde cerebral perfusion with inferior vena cava occlu-
sion was instituted. After the operation, all animals underwent daily
assessment of neurologic status until the time of death on day 7. Results:
Aortic arch return, cerebral vascular resistance, and oxygen extraction data
during retrograde cerebral perfusion showed differences, suggesting that
more effective flow occurs during retrograde cerebral perfusion with
inferior vena cava occlusion, which also resulted in more pronounced fluid
sequestration. Microsphere recovery from the brain revealed significantly
fewer emboli after retrograde cerebral perfusion with inferior vena cava
occlusion. Behavioral scores showed full recovery in all but one control
animal (after retrograde cerebral perfusion with inferior vena cava occlu-
sion) by day 7 but were considerably lower after embolization, with no
significant differences between groups. The extent of histopathologic injury
was not significantly different among embolized groups. Although no
histopathologic lesions were present in either the antegrade cerebral
perfusion control group or the retrograde cerebral perfusion control group,
mild significant ischemic damage occurred after retrograde cerebral per-
fusion with inferior vena cava occlusion even in control animals. Conclu-
sions: Although effective washout of particulate emboli from the brain can
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be achieved with retrograde cerebral perfusion with inferior vena cava
occlusion, no advantage of retrograde cerebral perfusion with inferior vena
cava occlusion after embolization is seen from behavioral scores, electro-
encephalographic recovery, or histopathologic examination; retrograde
cerebral perfusion with inferior vena cava occlusion results in greater fluid
sequestration and mild histopathologic injury even in control animals.
Retrograde cerebral perfusion with inferior vena cava occlusion shows clear
promise in the management of embolization, but further refinements must
be sought to address its still worrisome potential for harm. (J Thorac
Cardiovasc Surg 1998;115:1142-59)
Although use of hypothermic circulatory arrest(HCA) in the management of complex cardio-
vascular surgical procedures continues to enjoy
widespread clinical acceptance, there is persistent
concern about its efficacy in protecting the brain
when longer durations of HCA are required. Be-
cause highly complex problems requiring lengthy
periods of HCA are now being addressed more
frequently by operation, there is widespread interest
in the study of methods that might provide improved
cerebral safety under these circumstances. The use
of retrograde cerebral perfusion (RCP) was pro-
posed some years ago as a possible means of pro-
longing the safe duration of HCA and of dealing
with the catastrophic effects of both air and partic-
ulate emboli.1, 2
Fortunately, the incidence of severe cerebral
damage directly attributable to HCA remains rela-
tively small, but recent studies have confirmed the
suspicion that subclinical cerebral injury occurs in a
significant proportion of neonates after prolonged
HCA3-5 and that some degree of transient neuro-
logic injury occurs in a substantial number of adult
patients with long durations of HCA during aortic
arch operations.6 Because the overall results of
cardiac and aortic operations have steadily im-
proved in recent years and because the adult popu-
lation undergoing cardiac operations has gradually
aged, the patients in whom morbidity and/or death
are clearly a consequence of cerebral dysfunction
have increasingly become a major focus of concern.
Currently, there is a great deal of interest in strate-
gies to avoid cerebral emboli in patients with exten-
sive atheromatous disease who are undergoing ei-
ther an aortic or coronary artery bypass operation.7
In this atmosphere of the heightened awareness of
possible cerebral sequelae of cardiac and aortic
operations, RCP is especially appealing because it
may provide a way of improving neurologic outcome
both by reducing the incidence or mitigating the
severity of embolic injury and by increasing cerebral
protection during HCA.8-10
We have developed a chronic porcine model to
study RCP. We have thus far been able to dem-
onstrate that RCP results in a small amount of
nutritive flow and provides a degree of cerebral
protection during prolonged HCA that appears to
be superior to HCA alone, even when the head is
packed in ice.11 We have also investigated the
possibility that RCP might improve neurologic
outcome after particulate embolization to the
brain, but we were unable to demonstrate an
unequivocal benefit from the use of RCP in this
context, although we accumulated some encour-
aging data.12
The present study was undertaken to explore the
hypothesis that occluding the inferior vena cava
(IVC) during RCP (RCP-O) may provide more
effective washout of emboli than RCP without IVC
occlusion. The anticipated superiority of RCP-O
was based on two observations: that much of the
flow into the superior vena cava (SVC) during RCP
can be seen to be shunting into the lower resistance
IVC and that RCP in human cadavers takes place
largely via spinal cord collaterals fed by the azygos
and hemiazygos systems.13 We therefore expected
that we might be able to show improved outcome
after particulate embolization in our chronic porcine
model using this new approach to pressurize the
entire venous system during RCP.
In the current study, we have compared an inter-
val of RCP-O, RCP without IVC occlusion, and
continued antegrade cerebral perfusion (ACP) after
an ascending aortic injection of polystyrene micro-
spheres. Using saline solution-injected control ani-
mals, we have examined the impact of these inter-
ventions on the retention of microspheres in the
brain, cerebrovascular physiology and metabolism,
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electrophysiologic recovery, behavioral outcome,
and cerebral histologic evidence.
Materials and methods
Sixty juvenile Yorkshire pigs (Thomas D. Morris, Inc,
Reisterstown, Md.), 3 to 4 months of age, weighing 27 to
30 kg, were randomly assigned to groups to undergo 25
minutes of one of the following procedures at 20° C: ACP
control (AC); ACP after embolization (AE); RCP control
(RC); RCP after embolization (RE); RCP-O control
(RCO), and RCP-O after embolization (REO).
Preoperative management. All animals received hu-
mane care in accordance with the “Principles of Labora-
tory Animal Care” formulated by the National Society for
Medical Research and the “Guide for the Care and Use of
Laboratory Animals” prepared by the Institute of Labo-
ratory Animal Resources and published by the National
Institutes of Health (NIH publication No. 85-23 revised
1985). The protocol for these experiments was approved
by the Mount Sinai Institutional Animal Care and Use
Committee.
Anesthesia and hemodynamic monitoring. Anesthesia
was induced with ketamine hydrochloride (10 mg/kg in-
tramuscularly), and muscular paralysis was maintained
with pancuronium (0.1 mg/kg intravenously). After endo-
tracheal intubation, the animals were maintained on pos-
itive-pressure ventilation with 100% oxygen and isoflu-
rane anesthesia (1%). For monitoring, appropriate
catheters were positioned in the left femoral artery and
vein, in the pulmonary artery to measure cardiac output
by thermodilution, in the esophagus and rectum for
temperature, and in the bladder for urine output. The
sagittal sinus was also cannulated as previously described
for monitoring of pressure and blood withdrawal, and a
fine-wire temperature probe (IT-18; Physiotemp Instru-
ments Inc, Clifton, N.J.) was inserted into the epidural
space.11, 12
Electroencephalography (EEG) and evoked-potential
monitoring. Cortical electrical activity was monitored
from four stainless-steel screw electrodes (5 mm diame-
ter) implanted in the skull over the parietal and frontal
areas of the cortex. All EEG recordings were referenced
to a frontal screw electrode, which, with a ground screw
electrode, was implanted over the frontal sinuses. Process-
ing of the EEG, including amplification, filtration, digiti-
zation, storage, and analysis, was conducted on a Spec-
trum 32 data acquisition system (Cadwell Laboratories,
Kennewick, Wash.). Continuous EEG activity was re-
corded for 3 minutes at the time of each measurement.
Somatosensory-evoked potentials (SSEPs). SSEPs were
recorded from the cervical spine and bilateral skull sites in
response to stimulation of the median nerve. Electrical
stimulation (25 mA, 0.1 msec duration) of the median
nerve was accomplished through a pair of stainless-steel
needle electrodes that were inserted at the most distal
joint on the posterior surface of each forelimb.
The cervical recording electrode was a long stainless-
steel needle that was insulated except at the tip (imped-
ance , 3000 V). The electrode was inserted at approxi-
mately the second cervical vertebra and lowered until the
spine was contacted. The electrode and its wire lead were
held in place by a suture. For all recordings, a nose
reference was used. The most repeatable potential from
the cervical site was a negative-positive wave; the latency
of the negative wave was 6 to 8 msec, and the latency of
the positive peak was 8 to 10 msec.
Stainless-steel screws to which wire leads were soldered
served as the skull recording electrodes. The exact sites of
these electrodes were determined empirically in pilot
experiments by mapping the skull region overlying the
cerebral cortex while stimulating the median nerve. With
the use of a nose reference, a large negative-positive
complex could be recorded in all animals. The peak
latency of the negative potential was 17 to 19 msec. The
largest potentials were recorded at a site approximately
50% of the distance between the frontal and occipital
poles and approximately 10 mm lateral to the midline on
the side contralateral to the stimulation. The exact coor-
dinates were 10 mm anterior and 10 mm lateral to
bregma.
Two sets of SSEPs were recorded for each median
nerve at five of the six measurement time points described
in the experimental protocol. Each waveform was ob-
tained by averaging the responses to 500 stimuli. The
latencies and amplitudes were measured at 7 to 9 msec for
the positive cervical potential and at 19 to 21 msec for the
negative cortical potential in all animals. The amplitudes
of the responses at the first recording session were used as
a baseline. All subsequent amplitude measurements were
converted to a percent of the baseline.
Auditory brainstem–evoked responses (BSERs). BSERs
were recorded from all animals by averaging the responses
to 1000 presentations of an auditory click stimulus (95 db)
that was presented to the right ear through an ear insert
(Cadwell Laboratories). The sites of the recordings were
determined in pilot experiments. Probably because of the
mass and shape of the pig’s head, recordings from surface
electrodes placed near the ear produced unacceptable
levels of variability in the shape of the responses. On the
other hand, recordings from a cervical electrode (de-
scribed in the previous section) and referenced to a
Fig. 1. Mean (6 standard error of mean) esophageal,
rectal, and epidural temperatures at various time points in
60 pigs.
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cortical screw produced consistent waveforms in the pilot
animals.
The first repeatable wave was a positive potential at a
latency of 1.5 to 1.8 msec. This first wave was followed
consistently by a series of waves with interpeak latencies
of approximately 1.0 msec. In some animals, the second
positive wave was not distinct but was masked by the third
positive wave. In addition, the fifth positive wave in many
animals was not distinct and was merged with the fourth
wave. Although the first and fourth peaks in the BSERs
were the most consistent and could have been used for
analysis, we opted instead to measure the total spectral
power in all waves of the BSERs from 1.25 to 6.25 msec
after stimulus presentation. The total power of the BSER
at the first measurement time point was used as a baseline
for all subsequent measurements.
Cardiopulmonary bypass (CPB). Through a right tho-
racotomy in the fourth intercostal space, the azygos and
hemiazygos veins were ligated (the porcine hemiazygos
vein drains independently into the coronary sinus). The
SVC and aortic arch were mobilized, and the descending
aorta just distal to the left subclavian artery was exposed
by a retroesophageal approach. Twenty-gauge catheters
were positioned in the isolated aortic arch, the SVC, and
the IVC.
After heparinization (300 IU/kg), the ascending aorta
was cannulated with a 16F arterial cannula, and the right
atrial appendage was cannulated with a single 24F atrial
cannula; nonpulsatile CPB was initiated at 100 ml/kg per
minute. A cannula was passed from the right superior
pulmonary vein into the left ventricle to permit the
decompression of the left ventricle during CPB. Core
cooling was carried out with a heat exchanger, and surface
cooling was accomplished with a cooling blanket. A
membrane oxygenator (VPCML plus; Cobe Laboratories,
Inc., Lakewood, Colo.) was primed with 1 liter 0.9% NaCl,
1 unit 5% albumin, furosemide (1 mg/kg), heparin (5000
IU), and KCl (1 mEq/kg). The pH was maintained, with
alpha-stat principles, at 7.40 6 0.05 with an arterial carbon
dioxide tension of 35 to 40 mm Hg, uncorrected for
temperature.
Perfusion cooling was carried out for 25 minutes to
attain an esophageal temperature of 20° C. Cardiac arrest
was induced with potassium chloride (1 mEq/kg), and topical
cardiac cooling was begun and maintained throughout the
procedure. The ascending aorta was crossclamped just prox-
imal to the aortic cannula, and the descending aorta was
crossclamped distal to the left subclavian artery, thereby
isolating the transverse aortic arch.
Experimental protocol. After isolation of the aortic
arch, aortic arch pressure was slowly increased to 50 mm
Hg. When this pressure had been maintained for 60
seconds, a flow rate designated as preinjection flow was
recorded. Two hundred milligrams of polystyrene micro-
spheres 250 to 750 mm in diameter (coated with albumin
to minimize clustering and suspended in 10 ml saline
solution) were injected into the isolated aortic arch
through the aortic perfusion cannula in the embolized
groups; control groups were injected with saline solution.
If aortic arch pressure changed after the injection, CPB
flow was increased or decreased to maintain a pressure of
50 mm Hg. The resulting antegrade flow was then stabi-
lized (postinjection flow) and maintained for 5 minutes in
all groups; it was followed by 5 minutes of HCA during
which preparations for RCP were made as necessary. For
RCP, a 14F cannula was inserted into the SVC and
advanced as cranially as possible, snared in place, and
connected to the arterial line with a Y connector. In the
RCP-O groups the IVC was also snared, and a 10F
cannula was inserted into the descending aorta just distal
to the second crossclamp to permit collection of descend-
ing aortic return.
As dictated by the randomization protocol, a 25-minute
interval of ACP, RCP, or RCP-O was then initiated.
Retrograde flow was slowly increased and regulated to
achieve a pressure of 25 mm Hg in the sagittal sinus
during the first 10 minutes (prestable period). During the
subsequent 15 minutes, the CPB flow was kept constant
despite slight alterations in sagittal sinus pressure (stable
period). In animals undergoing RCP-O, maintenance of
adequate retrograde flow required infusion of 200 to 300
ml of blood obtained from donor pigs. In the ACP groups,
a pressure of 50 mm Hg in the aortic arch was maintained
throughout.
In the retrograde groups, perfusate returning from the
upper body to the isolated aortic arch, right atrium, and
Table I. Vascular resistance during stable selective perfusion
Group n
CPB flow
(ml/min)
Pressure (mm Hg)
Vascular resistance (mm Hg/ml/min)
SVC IVC
Upper body Lower body
SVC determined SS determined IVC determined
AC 10 188 6 47 — — — 7.77 6 1.91 —
AE 10 108 6 32* — — — 14.45 6 3.95 —
RC 10 254 6 158 67 6 39 21 6 4 9.23 6 11.04 3.70 6 4.5 —
RE 10 249 6 106 47 6 23 2 6 5 4.47 6 2.0 2.42 6 1.0 —
RCO 10 131 6 52 36 6 15 17 6 5 2.30 6 1.87 1.52 6 0.69 0.38 6 0.18
REO 10 177 6 52 44 6 28 22 6 5 1.94 6 1.03 1.34 6 0.51 0.33 6 0.13
AC, Saline control followed by antegrade cerebral perfusion; AE, microsphere embolization followed by antegrade cerebral perfusion; RC, saline injection
followed by retrograde cerebral perfusion; RE, microsphere embolization followed by retrograde cerebral perfusion; RCO, saline injection followed by
retrograde cerebral perfusion with occlusion of the inferior vena cava; REO, microsphere embolization followed by retrograde cerebral perfusion with
occlusion of the inferior vena cava; CPB, cardiopulmonary bypass; IVC, inferior vena cava, SVC, superior vena cava, SS, sagittal sinus. Values are shown as
mean 6 standard deviation.
*p 5 0.0003 compared with controls.
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descending aorta (only in RCP-O) was drained to collect-
ing chambers; its volume was measured and returned to
the pump. The amount of sequestered fluid was assessed
in all groups. In the retrograde groups, the microspheres
were recovered from the perfusate with a 40 mm transfu-
sion filter.
After 25 minutes of selective perfusion, all animals were
switched to ACP and rewarming was initiated. Ice slush
was removed from the chest; the blanket was turned to the
heating position, and an external heating source (lamp)
was used. Weaning from CPB occurred approximately 60
minutes after the beginning of rewarming, with cardiac
support provided by dobutamine; a single dose of furo-
semide (60 mg) and mannitol (12.5 gm) was administered.
Animals were extubated 1 hour after the last measure-
ment.
During the experiments, measurements were recorded
at six different times:
1. At baseline, 37° C (esophageal)
2. At the end of cooling, at 20° C, immediately before
institution of the intervention
3. During stable perfusion, at 20° C, 15 minutes after the
start of the intervention
4. During rewarming, at 30° C
5. Two hours after the start of rewarming
6. Four hours after the start of rewarming
Postoperative evaluation. Postoperatively, all animals
were evaluated daily with a previously described quanti-
tative behavioral score.11, 12 Each surviving animal was
killed on day 7. After being weighed, the brain was divided
in half, and the left side was immediately immersed in 4%
formalin for histologic analysis; the right side was pro-
cessed for microsphere recovery.
Microsphere recovery. After being sliced into small
pieces to increase its exposed surface area, the entire right
side of the brain was digested with 250 ml of a 10 mol/L
potassium hydroxide solution for at least 24 hours to allow
recovery of the microspheres. The solution was passed
through a 45 mm filter and flushed thoroughly; if neces-
sary, digestion and filtering were repeated 24 hours later
until no tissue was left. After being dried, the micro-
spheres were collected and weighed.
Histopathologic analysis. After fixation, the left hemi-
sphere of each brain was examined grossly. The cerebrum
was sectioned in the coronal plane; the brainstem, cere-
bellum, and 1.5 inches of the spinal cord were sectioned in
a horizontal plane. Sections were then processed into
paraffin, and 5 mm sections were stained with hematoxylin
and eosin.
Alternate coronal sections of the entire brain of each
animal were systematically examined by a single experi-
enced senior neuropathologist (D.W.), blinded both to the
experimental design and to the identity and fate of
individual animals. Each section was carefully screened
for the presence or absence of any infarctive or other
damage.
Definition of the anatomic regions scored was as previ-
ously described. Morphometric analysis of the volume of
ischemic injury of the cerebral cortex was classified in five
groups: 0 5 no microscopic ischemic damage identified in
any sections; 1 5 ,5% of total neocortex infarcted; 2 5
.5% but ,30% of total neocortex infarcted; 3 5 .30%
but ,70% of total neocortex infarcted; 4 5 .70% of total
neocortex infarcted. For all other anatomic regions, the
classifications were: 0 5 no microscopic ischemic damage
identified; 1 5 a single or multiple small infarctive lesions,
and 2 5 a large area of infarctive damage.
To allow quantitative comparisons, a total histologic
score was calculated by adding all the regional scores,
although we recognize that this is by no means a rigorous
quantitative assessment. A score of more than 4 means
that the animal had significant extracortical and cortical
injury.
Other measurements. Systemic arterial, venous, and
sagittal sinus blood samples were obtained to determine
pH, oxygen tension, carbon dioxide tension, oxygen satu-
ration, oxygen content, hematocrit, and hemoglobin
(Ciba-Corning Diagnostic Corp., Medfield, Mass.). Glu-
cose and lactate were analyzed with a YSI 2300 Stat
(Yellow Springs Instrument Co., Yellow Springs, Ohio).
Temperatures were also recorded at intervals throughout
the study.
Statistical analysis. Summary statistics for continuous
or ordinal variables were expressed as the mean 6
standard deviation, mean 6 standard error of mean, or as
Table II. Blood return and sequestration during selective perfusion
Group n
Return blood volume (ml) Return blood flow (ml/min)
Prestable period Stable period Stable period
Ascending
aorta
Descending
aorta
Right
atrium
Ascending
aorta
Descending
aorta Right atrium
Ascending
aorta
Descending
aorta
Right
atrium
AC 10 — — — — — — — — —
AE 10 — — — — — — — — —
RC 10 73 6 81 — 871 6 917 183 6 142 — 2147 6 1650 12 6 9 — 143 6 110
RE 10 84 6 27 — 1466 6 718 179 6 90 — 2718 6 1302 12 6 6 — 181 6 87
RCO 10 124 6 86 224 6 192 15 6 34 297 6 151* 802 6 359 9 6 18 20 6 10* 53 6 24 0.5 6 1.2
REO 10 100 6 59 203 6 144 2 6 4 295 6 119* 1106 6 395 2 6 7 20 6 8* 74 6 26 0.15 6 0.5
Values are shown as mean 6 standard deviation. Abbreviations as in Table I.
*When these control and embolism data for each perfusion method are pooled, they differ significantly from one another, as discussed in the text.
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the median. Statistical significance was determined by
one-way analysis of variance between the treatment
groups. Comparisons between each time point and base-
line were done by a set of paired t tests or Wilcoxon
signed-rank tests. Normality was tested first, and if it
failed, the analysis was performed with the corresponding
non-parametric tests (Wilcoxon or Kruskal-Wallis tests).
If significant differences were found by the one-way
analysis of variance, relevant pairwise comparisons were
performed and the significance levels were reported.
Categoric variables were compared by the use of x2 tests.
Significance levels are reported for comparisons with p ,
0.05. However, the levels of statistical significance should
be interpreted with caution, given the large number of
statistical tests performed. Analyses were performed with
a standard statistical program (SigmaStat, Jandel Corpo-
ration, San Rafael, Calif.).
Results
Physiologic data
Comparability of experimental groups. The mean
animal weight was 28.8 6 2.0 kg (mean 6 standard
deviation), with no significant differences between
groups. The CPB cooling time was 51 6 7 minutes,
and the warming time was 64 6 10 minutes (mean 6
standard deviation); these values also did not differ
significantly between experimental groups. Temper-
ature measurements also showed no significant dif-
ferences between experimental groups; after being
cooled to an esophageal temperature of 20° C, brain
(epidural) temperature was best approximated by
esophageal temperature, with rectal temperature
lagging behind. During rewarming, however, epi-
dural temperature more closely paralleled rectal
temperature (Fig. 1).
Hemodynamic data showed that all animals were
stable before, during, and after CPB, with only
minor variations in blood pressures and cardiac
output. No significant differences in these measure-
ments between embolized and control groups or
between groups undergoing different methods of
perfusion were recorded during the interventions,
but mean arterial pressures, for example, were sig-
nificantly different from baseline values at all subse-
quent time points, p , 0.001, dropping from a mean
(6 standard deviation) of 86 6 16 mm Hg at
baseline to 52 6 12 at the end of cooling, 57 6 10 at
30° C, and gradually reaching 62 6 9 by 4 hours after
the start of rewarming. Cardiac output also did not
differ significantly among the groups: 4.6 6 0.8
L/min at baseline, 4.3 6 1.0 at 2 hours, and 3.9 6
0.01 at 4 hours. CPB flow, too, was comparable in all
the groups, with a mean of 1.94 6 0.4 L/min at the
end of cooling and 2.4 6 0.4 L/min during rewarm-
ing.
Blood gas and hematocrit measurements (data
not shown) did not differ significantly between em-
bolized and control animals or between groups
undergoing different methods of perfusion except
during the period of the different interventions. A
significantly alkaline pH was seen in the RCP group
(RC, 7.59 6 0.11; RE 7.56 6 0.08), probably reflect-
ing the considerable volume of blood infused into
the SVC which is shunted into the IVC during RCP
if the IVC is not clamped, and is then recirculated
without having perfused any tissues.
A transient but significant drop in hematocrit
during RCP-O (RCO, 0.16 6 0.05; REO, 0.18 6
0.03, in contrast to 0.21 6 0.03 in the RCP group
[RC and RE] and 0.23 6 0.02 in the ACP group [AC
and AE]) reflects the considerable quantity of saline
solution that is required, in addition to donor blood,
to maintain adequate perfusion pressures during
RCP-O. Extracellular fluid sequestration during and
immediately after RCP-O resulted in the correction
of the hemodilution early during rewarming, with no
significant differences among the groups at that
point or thereafter.
Flow and vascular resistance before and after em-
bolization. The mean perfusion flow rate in the
isolated aortic arch during the 5 minutes of ACP
before embolization (preinjection flow) was 296 6
176 ml/min with the pressure maintained at 50 mm
Hg; it did not differ among the experimental groups.
The mean flow, with the aortic arch pressure still
maintained at 50 mm Hg, decreased distinctly after
microsphere injection but only slightly after saline-
solution injection (p , 0.0001). A statistically signif-
icant difference in vascular resistance after injection
was also seen between microsphere-injected and
saline solution control groups, p , 0.0001.
During the subsequent 25 minutes of ACP, the
mean flow rate was significantly higher in the AC
group than in the AE group, p 5 0.001 (Table I).
Blood sequestration (ml)
Prestable
period
Stable
period Total
76 6 121 217 6 58 59 6 124
90 6 122 25 6 72 115 6 145
541 6 286 1245 6 772 1786 6 1869
570 6 108 838 6 366 1408 6 406
1550 6 491* 1130 6 588 2680 6 967*
1458 6 464* 1722 6 737 3263 6 894*
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During the stable period of RCP, the flow rate was
higher in the groups without IVC occlusion whether
or not embolism had taken place: RCP, 251 6 31
ml/min versus RCP-O, 154 6 56 ml/min, p 5 0.004.
During the stable period, the mean SVC pressures
were also higher in the RCP than in the RCP-O
groups (RCP, 58 6 33 mm Hg versus RCP-O, 40 6
22 mm Hg, p 5 0.03) although the sagittal sinus
pressures, which determined flow, remained the
same. These data are consistent with the observa-
tion that much of the retrograde flow into the SVC
during RCP is shunted into the IVC if the IVC is not
clamped.
Vascular resistances during the stable period were
calculated separately based on the SVC and sagittal
sinus pressures (Table I). Although no statistically
significant differences were found between control
and embolized groups (RC versus RE or RCO
versus REO), a highly significant difference (p ,
0.0001) was found in vascular resistance when data
from embolized and saline solution groups were
pooled (20 animals in each group) to compare RCP
without and with IVC occlusion. Vascular resistance
during RCP was 6.9 6 8.1 mm Hg/ml per minute
versus 2.1 6 1.5 mm Hg/ml per minute during
RCP-O (with the use of SVC pressures). Sagittal
sinus–determined vascular resistances also differed
between the pooled groups: RCP, 3.1 6 3.3 mm
Hg/min versus RCP-O, 1.4 6 0.6 mm Hg/ml per
minute, p 5 0.03. The higher vascular resistance
during RCP when compared with RCP-O may be
due in part to the higher pH of the perfusate in
RCP; alkaline pH is known to cause cerebral vaso-
constriction.
Thus embolization had a significant impact on
flow and vascular resistance in the ACP group. In
the various RCP groups, the differences in flow and
vascular resistance as the result of embolization did
not reach statistical significance. However, occlusion
of the IVC during RCP did induce statistically
significant differences in flow and vascular resistance
in the combined saline solution and embolism
groups. The animals with RCP-O had significantly
lower absolute flow rates and consistently lower
SVC pressures and cerebral vascular resistances
compared with RCP without IVC occlusion.
Table III. Cerebral metabolism
n
Baseline
(37° C)
End of CBP
cooling
(20° C)
Stable ACP/
RCP
(20° C)
After start of rewarming
(30° C) 2 Hr 4 Hr
Sagittal sinus lactate (mmol/L)
AC 10 1.1 6 0.5 1.7 6 0.8** 2.5 6 0.7** 4.2 6 1.3*** 3.3 6 1.5** 1.8 6 1.0
AE 10 1.1 6 0.4 1.7 6 0.4** 2.6 6 0.5*** 5.2 6 0.9*** 3.9 6 1.0*** 2.3 6 0.9**
RC 10 1.2 6 0.4 1.8 6 0.6** 2.9 6 0.9** 5.1 6 1.2** 4.0 6 1.3*** 2.3 6 0.8**
RE 10 1.3 6 0.4 2.1 6 0.8** 3.5 6 1.2*** 6.0 6 1.9*** 4.3 6 1.8*** 2.6 6 0.9**
RCO 10 1.5 6 0.8 2.1 6 0.5* 3.4 6 0.7*** 6.1 6 1.4*** 4.6 6 2.6** 3.4 6 2.7
REO 10 1.4 6 0.7 2.1 6 0.3** 3.6 6 0.4*** 5.8 6 0.8*** 4.3 6 1.2*** 3.3 6 1.4**
Mean 10 1.3 6 0.5 1.9 6 0.6* 3.2 6 0.9*** 5.4 6 1.4*** 4.4 6 1.8*** 2.6 6 1.5**
Cerebral glucose difference (mg/dl)
AC 10 4.7 6 2.5 3.7 6 2.3 5.7 6 7.0 11.9 6 4.9** 4.9 6 4.8 7.0 6 11.5
AE 10 6.5 6 2.3 5.1 6 7.0 5.8 6 4.6 9.0 6 11.0 7.9 6 2.8 8.6 6 4.1
RC 10 6.1 6 2.7 3.4 6 2.3 28.0 6 28.7 8.6 6 5.8 11.3 6 6.0 4.8 6 3.2
RE 10 6.3 6 4.2 3.6 6 2.6 13.5 6 7.8 10.3 6 6.1 3.0 6 5.4 7.8 6 6.5
RCO 10 8.2 6 3.4 4.3 6 4.8 26.8 6 13.5** 9.9 6 13.4 9.6 6 3.2 7.5 6 4.0
REO 10 5.7 6 5.5 4.3 6 3.0 22.1 6 26.1 12.0 6 8.4 7.0 6 6.5 8.0 6 10.0
Cerebral oxygen difference (mg/dl)
AC 10 3.0 6 1.5 2.2 6 0.7 3.4 6 3.0 4.4 6 1.1 4.2 6 1.2 4.8 6 1.9*
AE 10 3.4 6 0.6 2.1 6 1.1* 3.2 6 1.3 3.3 6 1.0 4.7 6 0.9** 5.2 6 1.7*
RC 10 3.2 6 0.6 1.7 6 0.7* 7.1 6 1.4** 2.2 6 0.3** 3.0 6 0.7* 4.4 6 1.8
RE 10 4.1 6 1.5 1.3 6 0.9** 7.7 6 1.1** 2.6 6 1.3 3.4 6 1.5 4.3 6 2.1
RCO 10 3.4 6 1.1 2.0 6 1.0** 4.8 6 2.0 2.3 6 1.3* 5.3 6 0.9*** 5.1 6 1.1*
REO 10 3.5 6 1.4 2.2 6 1.2** 5.5 6 1.5** 2.6 6 1.1** 3.7 6 2.0 4.1 6 2.3
Values are shown as mean 6 standard deviation. Abbreviations as in Table I.
*p , 0.05.
**p , 0.01.
***p , 0.0001 compared to baseline.
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Blood return/fluid sequestration. Little if any fluid
sequestration, calculated as the difference between
total inflow and venous return, was detected in the
ACP groups during the 25 minutes after injection
whether or not embolization had taken place (Table
II); there was no difference between the embolized
group and the control. Similarly, in the RCP groups,
no significant differences were found in venous
return or sequestration rates when comparing RC
versus RE or RCO versus REO groups, but signif-
icant differences between the two methods of retro-
grade perfusion (RCP versus RCP-O) were found
when data from the RC and RE groups were pooled
and compared with pooled data from RCE and
RCO groups. Although the volume of desaturated
blood returned to the aortic arch was slightly smaller
with RCP during the prestable period, this differ-
ence did not reach statistical significance. However,
during the subsequent period of stable perfusion,
there was significantly less blood returning to the
aortic arch in the RCP group: RCP, 208 6 136 ml
versus RCP-O, 296 6 132 ml, p 5 0.02. In terms of
flow rates, the difference was also significant (RCP,
12 6 9 ml/min versus RCP-O, 20 6 9 ml/min, p 5
0.02), with higher flow rates when the IVC was
occluded.
However, the total amount of fluid sequestered
(Table II) was distinctly higher in the RCP-O groups
(2956 6 955 ml with RCP-O versus 1621 6 776 ml
with RCP, p , 0.0001). The major difference be-
tween the RCP groups occurred during the
prestable period (RCP-O, 1504 6 468 ml versus
RCP, 587 6 256 ml, p , 0.0001) whereas seques-
tration during the stable period had only marginal
statistical significance (RCP-O, 1426 6 716 ml ver-
sus RCP, 1035 6 641 ml, p 5 0.08).
Thus more effective cerebral perfusion during
RCP-O was seen, judged both by a higher rate of
aortic arch flow and a higher volume of blood
returned to the arch, but this more effective cerebral
blood flow was accompanied by increased extracel-
lular fluid sequestration, especially during the first
few minutes of RCP.
Metabolic data. Sagittal sinus lactate and arterio-
venous cerebral glucose differences at six measure-
ment time points are depicted in Table III. As was
the case with the hemodynamic measurements, sig-
nificant differences were seen between embolized
groups and their control groups only in the groups
with ACP; but there were a number of measure-
ments that differed among pooled embolism and
control groups subjected to different methods of
perfusion.
Sagittal sinus lactate increased progressively dur-
ing cooling to 20° C and during the stable perfusion
period, with the highest values being found during
rewarming at 30° C. Significantly higher values (p 5
0.02) were seen in all retrograde groups than were
present during or after ACP, suggesting a greater
degree of anaerobic metabolism during and imme-
diately after RCP than during continued ACP.
Distinct differences were found between ACP and
the two methods of RCP in glucose metabolism
during the 25 minutes of differing perfusion (Table
III). In the ACP groups, the mean cerebral glucose
extraction was 5.7 6 5.9 mmol/L, whereas in the
RCP groups the equivalent extraction (between the
SVC arterial line and the aortic arch return) was
20.3 6 21.0 mmol/L. In the RCP-O groups, by
contrast, it would seem that no glucose was ex-
tracted; the mean pooled value was –4.4 6 20.3
mmol/L, (p , 0.001). The fact that glucose extrac-
tion did take place in the RCP group argues that
some nutritive function is performed by retrograde
flow; the greater glucose extraction during RCP
than during ACP probably reflects compensation for
the much lower cerebral blood flow that occurs
during RCP. Although RCP-O provided greater
Table IV. Oxygen extraction and consumption
Group n
Blood flow (ml/min) Oxygen extraction (ml/dl) Oxygen consumption (ml/min)
Upper body Lower body Upper body Lower body Upper body Lower body
AC 10 188 6 48 — 3.5 6 1.0 — 6.1 6 1.5* —
AE 10 108 6 32 — 4.4 6 1.2 — 4.5 6 1.1* —
RC 10 12 6 9 143 6 110 7.1 6 1.4* 0.4 6 0.3 0.8 6 0.6 0.5 6 0.5
RE 10 12 6 6 181 6 87 7.7 6 1.1* 1.2 6 3.5 0.9 6 0.5 1.4 6 4.1
RCO 10 20 6 10 53 6 24 4.8 6 2.1 5.5 6 2.2 1.3 6 1.6 2.5 6 08
REO 10 20 6 8 74 6 26 5.5 6 1.5 5.8 6 1.8 1.2 6 07 4.5 6 1.9
Values are shown as mean 6 standard deviation. Abbreviations as in Table I.
*When these control and embolism data for each perfusion method are pooled, they differ significantly from one another, as discussed in the text.
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effective flow than RCP, flow was still not as high as
with ACP; so the failure to note any glucose extrac-
tion during RCP-O most likely reflects some unex-
pected confounding factor, such as admixture of
hepatic venous blood, which is high in glucose,
during RCP-O.
This interpretation of the glucose extraction data
was upheld when the oxygen extraction data was
examined (Tables III and IV), which are inversely
related to effective flow and therefore, as expected,
show lower extraction with ACP than with either
RCP (p , 0.0001) or RCP-O (p 5 0.01) and
significantly lower extraction with RCP-O than with
RCP, p , 0.001 (the mean values in upper-body
oxygen extraction were ACP, 3.3 6 2.3 ml/dl; RCP,
7.4 6 1.2 ml/dl; and RCP-O, 5.2 ml/dl).
The oxygen consumption data (Table IV) reflect
the physiologic consequences of flow rates and
oxygen extraction. Oxygen consumption was highest
during ACP: ACP, 5.35 6 1.5 ml/min; RCP, 0.86 6
0.54 ml/min; RCP-O, 1.25 6 1.16 ml/min; ACP
versus all forms of RCP, p , 0.001. The oxygen
consumption during RCP-O was not significantly
higher than cerebral metabolic rate of oxygen during
RCP, however.
Summary of physiologic data. When the physio-
logic data are examined overall, it is clear that ACP
provides the most efficient flow, sustaining much
higher levels of cerebral oxygen consumption than
retrograde flow, although still falling short of ideal
perfusion as evidenced by the presence of lactate
levels significantly higher than baseline. RCP-O
allows better perfusion than RCP, with significantly
lower vascular resistance, higher flow, and lower
oxygen extraction, although not significantly higher
oxygen consumption. However, RCP-O also results
in significantly higher levels of fluid sequestration
than RCP. Some of the enhanced flow seen with
RCP-O compared with RCP may be due to vaso-
constriction induced by the higher pH of the perfus-
ate during RCP.
Microsphere recovery (Fig. 2). There was a sig-
nificant difference in microsphere recovery among
the three embolized groups; nearly twice the num-
ber of microspheres were recovered from the brains
in the AE group and the RE group than from the
REO group (p 5 0.03). The differences in micro-
sphere recovery indicate that RCP-O was quite
effective in the desired goal of washing out micro-
spheres from the brains of embolized animals,
whereas RCP without IVC occlusion left as many
microspheres lodged in the brain as continued ACP.
The success in removal of microspheres from the
brains of the animals that were subjected to RCP-O
is in accord with the data on aortic arch return and
oxygen extraction, which also indicate that effective
cerebral perfusion takes place during RCP-O.
Morbidity and death. All animals were stable
during the surgical procedures. Forty-one of the 60
animals survived for the full 7 days of the experi-
ment, enabling their daily behavioral scores to be
recorded throughout. Premature deaths occurred in
18 of 30 embolized animals and in 1 of 30 control
animals (p , 0.0001).
The 7-day deaths in the various embolized groups
did not differ significantly among the groups: AE 5
5, RE 5 7, and REO 5 6. The often severely
affected animals in the embolized groups were fre-
quently unable to stand, had poor appetite and
abnormal reflexes, and either died spontaneously or
were killed early to avoid excessive suffering. The
only control animal that failed to survive for the full
7 days was from the RCO group; this pig exhibited
substantial neurologic impairment, and postmortem
examination revealed a large subdural hematoma
that covered the entire cortex and brainstem and
extended along the spinal cord.
Behavioral outcome. As shown in Fig. 3, neuro-
logic recovery after 7 days was essentially complete
in the control animals, although some minor behav-
ioral abnormalities were evident in the first few days
in some control animals after RCP-O (Fig. 4). After
Fig. 2. Microsphere recovery from the right hemisphere
of the brain after digestion with potassium hydroxide in
animals treated with different methods of perfusion after
embolization. All data points and median recovery in each
group are depicted. A significantly lower number of
residual emboli were found after RCP-O than in the other
perfusion groups. Abbreviations as in Table I.
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embolization, the behavioral outcomes of the ani-
mals were significantly poorer than in the control
groups but similar to one another, with no signifi-
cant differences between AE, RE, and REO groups.
Among the animals that survived for 7 days, the
neurologic outcome was distinctly better in control
animals (p 5 0.001); all control animals had a score
of more than 8 one week after intervention, whereas
only four animals in the AE group and two animals
in each of the RE and REO groups had scores of
more than 8 after 1 week.
EEG and evoked potentials (QEEG; Fig. 5). No
difference was found in total EEG power (0.5 to 20
Hz) between any of the groups at baseline or at the
end of cooling; EEG was isoelectric at 20° C in all of
the animals. At 30° C during rewarming, animals in
the antegrade groups had earlier EEG return than
those in the retrograde groups. The EEG return 4
hours after intervention reflects a much more rapid
recovery with ACP than with either method of RCP.
In addition, there is a strong effect of embolism on
QEEG return; the AC and RC groups show signif-
icantly higher return of baseline QEEG 4 hours
after the start of rewarming than the AE and RE
groups, p , 0.001, although there is no significant
difference between the RCO and RCE groups in the
pattern of EEG recovery.
SSEP. In general, the recovery of cortical SSEPs
followed a pattern similar to the recovery of cortical
QEEG (data not shown). During rewarming and 2
and 4 hours thereafter, the AC group showed the
greatest recovery of cortical amplitude. As with
QEEG, by 4 hours after the start of rewarming, the
amplitude of cortical response to somatosensory
stimulation in the AC group was significantly greater
than AE amplitude, and RC amplitude was signifi-
cantly better than RE amplitude. Again, as with
QEEG, however, both groups with RCP-O showed
delayed recovery. At no time did the RCO group
show greater recovery than the REO group. In
contrast to cortical SSEP recovery, cervical SSEP
recovery (data not shown) was quite prompt, with
essentially full recovery by 2 hours after the start of
rewarming and no significant differences between
embolized groups and control groups or between
ACP, RCP, and RCP-O groups.
BSERs. Analysis of BSER potentials (Fig. 6) was
restricted to those animals (35 of 60) in which
repeatable responses could be obtained at all mea-
surement time points. Many animals were excluded
because some of their tracings had poor signal-to-
noise levels and was not due to any characteristics of
the animals, as far as we are aware. Like the cervical
responses to somatosensory stimuli, BSERs showed
early recovery. At 30° C, approximately 40% recov-
ery of BSERs was seen in all except the REO group.
By 2 hours after the start of rewarming, however,
the total power in the RCO group had dropped, and
this trend continued at the 4-hour time point in the
RCO group although the response in the other
groups remained stable. Analysis of variance of
BSER recovery at 4 hours revealed a significant
effect of perfusion method (p 5 0.006), which was
due solely to the poorer recovery in the two retro-
grade occlusion groups.
Analysis of the individual BSERs in the RCO
group revealed that four of the six animals in this
group showed a pattern like the one in Fig. 7, a good
recovery at 30° C followed by a complete loss of the
response by 4 hours after the start of rewarming.
This pattern suggests that the ultimate failure of
complete return of function in this control group
may not reflect intraoperative injury, as seen in the
embolized animals, but rather a later insult. Such a
dampening of brainstem auditory–evoked poten-
tials late after the operation could be attributed to
the development of cerebral edema.
Fig. 3. Median daily behavioral scores after emboliza-
tion, or after saline solution injection in control animals,
followed by various methods of hypothermic perfusion.
There was almost complete recovery by day 7 in most of
the control animals, whereas persistent impairment was
present in many of the embolized animals in all perfusion
categories, with no significant differences among emboli-
zed groups or among control groups. The behavioral score
reflects appetite, mental status, and motor function. A
score of 9 indicates complete recovery, and 0 indicates
coma or death. Abbreviations as in Table I.
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Histopathologic results. Brains could be recov-
ered for histopathologic studies in 54 animals. In
81% (21 of 26) of control animals, histopathologic
scoring of the cortex was 0, indicating absence of any
pathologic damage, but this was true in only 7% (2
of 27) of the embolized animals (p , 0.0001).
Among the control animals, 9 of 9 AC, 8 of 8 RC,
but only 4 of 9 RCO animals had no cortical
pathologic damage (p 5 0.003), paralleling the
pattern of behavioral recovery in which RCO ani-
mals fared more poorly than the other control
animals. Although the median cortical histopatho-
logic score for the RCO group was 1, indicating only
mild pathologic damage, two animals in this control
group had a moderate number of cortical defects. No
differences in the intrinsic characteristics of his-
topathologic lesions were evident when embolized
animals and RCO groups were compared. It should be
borne in mind that any direct evidence of cerebral
edema, which may have initiated the ischemic damage
seen in the control animals, would no longer be
expected to be present 1 week after the operation.
By adding together the scores from each area of
the brain examined, one can arrive at a total his-
Fig. 4. Daily behavioral score of each animal in each group after embolization or saline solution injection.
Abbreviations as in Table I and scores as in Fig. 3.
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topathologic score for each animal; the individual
scores and the median for each experimental group
are shown in Fig. 8. After embolization, the highest
score was in the AE group and the lowest score was
in the RCP-O group, but the trend toward lower
scores after embolization with increasingly effective
retrograde perfusion is not statistically significant.
The median scores for histopathologic outcome
just in the cerebral neocortex were AE 5 1, RE 5
3, and REO 5 3, p 5 0.15, suggesting that no
improved histologic outcome after embolization re-
sulted from either form of retrograde perfusion. These
results are in accord with the evidence from behavioral
scores, which also failed to show improvement in
Fig. 5. Mean (6 standard error of mean) total EEG power, as a percent of baseline recordings at 37° C,
in each group during recovery from embolization or saline solution injection followed by different methods
of perfusion. Recovery of EEG was monitored during early rewarming (at 30° C) and at 2 and 4 hours after
the start of rewarming. Return of EEG was significantly more rapid after ACP than after either method
of RCP. Four hours after the start of rewarming, EEG power was significantly greater in control animals
than in embolized animals when either ACP or RCP without IVC occlusion were used, AC versus AE and
RC versus RE, p , 0.001, but no difference in recovery of EEG was seen between embolized and saline
solution–injected control animals subsequently subjected to RCP-O (RCO versus REO). Abbreviations as
in Table I.
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outcome if retrograde perfusion was instituted after
embolization.
If the distribution of lesions within the brain is
examined in those groups in which histologic dam-
age was observed, which includes all the embolized
groups and the RCO control (Fig. 9), it can be seen
that some differences are present. The pure embo-
lism pattern seen in the AE group shows lesions in
the neocortex, deep cerebrum, and cerebellum;
whereas with pure retrograde perfusion-induced
Fig. 6. Mean (6 standard error of mean) total power of brainstem auditory–evoked potentials (as a
percent of baseline BSERs) during recovery after embolization or saline solution injection followed by
various methods of hypothermic cerebral perfusion, with groups and time points as in Figure 5. Results are
from 35 of 60 animals because low signal-to-noise levels precluded a complete set of reliable recordings in
the remaining animals. Early recovery to .40% of baseline values was present in all but the REO group,
which (as also observed with cervical SSEP) never showed a good response after the operation. Whereas
the rapid recovery of BSERs in most groups was sustained, in the RCO group there was a drop in BSER
power at 2 hours and a further drop at 4 hours. At the 4-hour time point, the recovery of BSER in both
groups in which RCP-O was used was significantly poorer than recovery after either ACP or RCP, p 5
0.002. Abbreviations as in Table I.
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damage (seen in the RCO group), most of the
lesions are in the neocortex. The findings in both the
deep cerebrum (p 5 0.02) and in the cerebellum
(p 5 0.005) show highly significant differences be-
tween the AE and RCO groups. The patterns in the
RE and REO groups are very similar to one an-
other, with more neocortical lesions than in either
the AE or RCO groups, and suggest the possibility
that embolic and retroperfusion-induced histopa-
thology may be additive. There is a marginally
significant difference between the AE and RE
groups in the neocortex, p 5 0.06. In the deep
cerebrum, the pattern in the RE and REO groups is
compatible with the possibility that retrograde per-
fusion may have mitigated embolic injury. The only
statistically significant differences are between the
RCO and all embolized groups.
Discussion
The data from this study confirm earlier work that
suggested that RCP can provide effective retrograde
flow to the brain. To our knowledge, ours is the first
study that indicates that more efficient RCP can be
achieved via the SVC if the IVC is occluded (RCP-
O). The higher rate of return of blood to the
isolated aortic arch, the lower cerebral-vascular
resistance, and the reduced oxygen extraction all
suggest that RCP-O is more effective than RCP
without IVC occlusion. The rise in the pH of the
perfusate when RCP is carried out without the IVC
clamped may have contributed to the decreased flow
and enhanced vascular resistance seen with this
method; but although a higher pH would be ex-
pected to result in enhanced vasoconstriction and
therefore diminished flow, studies by others14, 15
have indicated that intracellular pH falls quite rap-
idly during RCP. This intracellular acidosis would
probably effectively counteract any vasoconstrictive
impact of the small volume of alkaline retrograde
flow.
In addition to the hemodynamic and metabolic
evidence, the demonstrated washout of micro-
spheres from the brain in the RCP-O group con-
firms the efficacy of this technique. The unequivocal
microsphere data should finally lay to rest the
contention that RCP cannot perfuse the brain and
that retrograde flow is confined to the meninges.16
Our results are based on a comparison of micro-
spheres recovered when the parenchyma of the
brains of the animals were digested after emboliza-
tion and subsequent ACP or RCP. Because fewer
emboli remained in the REO group than the AE or
RE group, one must conclude that the microspheres
were indeed flushed from the brain during RCP-O.
The successful removal of microspheres by
RCP-O after embolization is encouraging for those
who see promise in this method for the prevention
of strokes after cardiac or aortic operation. But the
absence of improved neurologic or histopathologic
outcome in the REO animals, despite the effective
removal of emboli, suggests that the conditions
under which RCP were being carried out in this
study are still far from optimal and echo the results
from our previous study, which suggested that some
animals may be harmed by RCP after emboliza-
tion.12 The neurologic morbidity evident even in
control animals after RCP-O suggests that there is
inherent potential for cerebral injury with this form
Fig. 7. The brainstem auditory–evoked potential re-
sponse pattern in four of six saline solution–injected
control animals subsequently perfused retrograde with the
IVC occluded (RCO). An initial recovery of the BSER
can be seen by comparing the response at 30° C with the
baseline recording. At 2 hours after the start of rewarm-
ing, however, the BSER was flat (1.6 msec loss of wave 1),
and there was still no response 4 hours after the start of
rewarming. The loss of the BSER after initial recovery
suggests that these animals had a time-dependent or
temperature-dependent insult later during recovery than
in the REO group, where a likely intraoperative insult
prevented even early return of the BSER. At zero latency,
the stimulus would be expected to reach the tympanic
membrane.
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of RCP, at least under the circumstances that pre-
vailed in this study, even in the absence of any
additional insult such as embolization. If RCP is to
be considered for clinical use with the hope of
reducing embolic injury after cardiac and aortic
operations, it is important to try to determine
whether the possible benefit of RCP can be dissoci-
ated from its potential for harm.
If one looks carefully at all the data, the most
striking finding is the large amount of sequestered
fluid that accumulates during RCP, particularly if
the IVC is occluded. It seems quite plausible that
this sequestered fluid might manifest itself to some
degree as cerebral edema, which is certainly a
potential cause of neurologic morbidity. The fact
that the mean weight of the brains in the 19 animals
that were killed within the first 24 hours was 86 6
7 g, significantly higher than the mean brain weight
(78 6 5 g) of the remaining 41 animals that lived
until day 7 (p , 0.001) suggests that cerebral edema
was present in the animals that died early. Cerebral
edema has been shown by a number of investigators
to occur after RCP. Its severity has been observed to
be related both to perfusion pressure and to dura-
tion of RCP.17, 18 In our previous study, high SVC
perfusion pressures appeared to be associated with a
poorer outcome despite uniformity of sagittal sinus
pressures. In this study, several technical modifica-
tions were introduced, and the relationship between
high SVC pressure and poor outcome was no longer
observed.12 In the current study, ligation of the
hemiazygos vein was routinely carried out; higher
perfusion pressures, when necessary, were achieved
more gradually, and the sagittal sinus pressures that
regulated flow were lower. These modifications may
have reduced the development of cerebral edema
during RCP.
In careful scrutiny of electrophysiologic recovery,
the initial rapid early recovery of brainstem audito-
ry–evoked potentials in all control groups, including
the RCO, and the selective diminution of this
response selectively in the RCO group at the later
time points is also striking. This pattern is in contrast
to the recovery of EEG and cortical-evoked re-
sponses in embolized animals, in which a consistent
pattern of delayed and diminished but steadily pro-
gressive recovery throughout the period of postop-
erative surveillance is seen. The disappearance of
the auditory-evoked response after an initial good
recovery in several animals in the RCO group (Fig.
7) is even more impressive than the mean response
and is suggestive of a postoperative rather than an
intraoperative insult. Such a postoperative insult
could be a consequence of the development of
cerebral edema after RCP-O.
In the animals with embolization followed by
RCP-O, the pattern of recovery followed by dimi-
nution in the brainstem-evoked potentials was not
seen, probably because there was also an intraoper-
ative insult occasioned by the microspheres not
removed by RCP, which prevented the early recov-
ery seen in the control animals. The combination of
even minor intraoperative injury and the later de-
velopment of cerebral edema would explain our
failure to see any statistically significant benefit in
terms of death or improved histologic or behavioral
recovery in the REO group despite the successful
removal of a significant number of emboli. But if
absolutely no benefit had been rendered by removal
of emboli by RCP-O, one would expect that the
REO group would have had a significantly worse
outcome not only than the RCO group but also
compared with the RE and the AE groups. This was
not apparent; in fact, the histologic result in the
REO group was somewhat better than in the other
embolized groups.
Fig. 8. Total histopathologic score in all animals after
embolization or saline solution injection followed by
different methods of hypothermic perfusion, with medians
in all groups. A higher score indicates a greater degree of
cerebral histopathologic damage. The total was derived by
adding the scores of the different regions of the brain
examined and is weighted toward neocortical pathology
damage. Although a trend toward lower median scores
after embolization when followed by increasingly effective
retrograde perfusion is evident, these differences did not
reach statistical significance. It should be noted that the
only histopathologic injury among the control groups
occurred after RCP-O. Abbreviations as in Table I.
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The improvement in behavioral scores between
day 1 and 7 after the operation in a number of
survivors of the current protocol could reflect reso-
lution of mild, transient cerebral edema in many of
these animals. Cerebral edema was probably most
severe in the groups with RCP-O, in whom the
greatest degree of fluid sequestration was observed.
We speculate that more aggressive attempts to
prevent or treat cerebral edema might have allowed
more rapid recovery in more animals both in the
embolized and in the control groups and might even
have improved survival in those that were killed
early or died spontaneously, in which the presence
of cerebral edema was suspected on the basis of
higher brain weight. Because the animals in this
experiment were killed 1 week after the operation,
one would not anticipate being able to document the
presence of cerebral edema on histopathologic ex-
amination but only its sequelae.
If it is true that the late development of cerebral
edema can explain both the failure of complete
recovery in the control animals after RCP-O and the
failure to see an unequivocal benefit in terms of
histologic and behavioral outcome from the removal
of emboli in the REO group, then it is conceivable
that, with some modifications, RCP could still prove
useful as a treatment for particulate embolization.
Perhaps the interval of RCP could be shortened, or
the potential for cerebral edema could be combated
with diuretics and other pharmacologic strategies
more vigorously and for a much greater interval
after the operation. In the current protocol, only
minimal precautions were taken to forestall devel-
opment of cerebral edema; steroids were not admin-
istered, and only one dose of furosemide and man-
nitol were given at the time of weaning from CPB.
Yoshimura and his colleagues19 have shown that the
cerebral edema that develops in dogs after RCP can
be significantly reduced with mannitol and antivaso-
spastic substance, especially if drugs are adminis-
tered both during CPB and for several hours after
the operation. It is also conceivable that adjustments
in the rate of retrograde flow, which in this protocol
was regulated to achieve a given sagittal sinus
pressure, might be helpful in limiting the develop-
ment of cerebral edema without diminishing the
effectiveness of RCP.
In summary, our data clearly show that RCP-O
provides effective cerebral perfusion, including mea-
surably significant removal of particulate emboli.
The potential benefit of this strategy, however,
seems unfortunately to be accompanied by a poten-
Fig. 9. Histopathologic scores in different areas of the
brain in the four experimental groups in which histopatho-
logic injury was evident, with median values. The distri-
bution of lesions in the AE group can be considered the
pattern of damage after embolization and the distribution
in the RCO group, in which no emboli were involved, the
pattern of damage induced by RCP. In the deep cerebrum
(p 5 0.02) and in the cerebellum (p 5 0.005), the
differences between the AE and RCO groups are highly
significant. The damage in the RE and REO groups
exhibit some features of each pattern; the relatively high
neocortical scores in both these groups look as though
there might be an additive effect of embolic and perfu-
sion-related injury. In fact, the difference between AE and
RE groups in the neocortex is marginally statistically
significant, p 5 0.06. In the deep cerebrum, RCP may have
mitigated injury, but only the differences between the
RCO and all the embolism groups were statistically
significant. Again in the cerebellum, RCO was signifi-
cantly different (p 5 0.03) from the REO and the AE
group. Abbreviations as in Table I.
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tial for cerebral injury, even with a relatively short
interval of RCP, even in control animals. Until the
mechanism of this injury is better understood, RCP
should be used sparingly in the clinical setting, and
precautions should be taken to minimize postoper-
ative cerebral edema.
It should perhaps be noted that the central obser-
vation of this study, that RCP-O can remove partic-
ulate emboli, might have been interpreted quite
differently had behavioral evaluation, neurophysio-
logic recovery, and cerebral histologic examination
not been carried out. Given the enthusiasm with
which RCP has been adopted for clinical use despite
only fragmentary understanding of its physiolo-
gy,8-10 it seems especially important to remember
that laboratory studies that do not include some
reliable measures of neurologic outcome must be
interpreted with caution.
We thank Howard Shiang, DVM, Richard Smith, Rich-
ard Henry, Michael Nurzia, and Russell Jenkins for
invaluable technical assistance.
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Discussion
Dr. D. Craig Miller (Stanford, Calif.). The first thing I
would like to do is remind the audience that we are now
celebrating the twenty-second anniversary of the first
meeting of the Samson Thoracic Surgical Society held in
Santa Barbara where Dr. Griepp initially presented his
seminal work on the use of HCA for aortic arch surgery,
something the Western Thoracic Surgical Association can
certainly be proud of (J Thorac Cardiovasc Surg 1975;70:
1051-63).
Dr. Juvonen is a cardiac surgeon from Finland who has
been working in Dr. Griepp’s laboratory for 21⁄2 years. Dr.
Griepp and Dr. Juvonen, in typical surgical fashion, have
taken something we think works clinically back to the
laboratory to figure out if it works, and if it does, why it
works.
You are correct, Dr. Juvonen, in that there is growing
clinical uncertainty about the purported benefits and the
unknown risks of RCP.
I thought the most constructive thing I could do was try
to distill for the audience the important central points that
you have made:
1. As one might expect, blowing small pieces of plastic up
into the brain is not good, even in pigs.
2. RCP blood flow does, indeed, get to the deep cerebral
and cerebellar brain matter; your work is, to the best of
my knowledge, the first time that this effect has been
firmly established. Many have thought in the past that
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RCP flow mostly perfuses the dural sinuses and the
meninges.
3. RCP can actually flush out particulate emboli from the
brain, something that has only been assumed before.
4. RCP done properly, meaning with the IVC occluded, is
superior in terms of removing emboli compared with
the usual fashion in which RCP is carried out but, as
you have illustrated, does appear to have separate
injurious and deleterious affects on the brain.
As you mentioned, this brain injury was even observed in
the control animals without embolization; it is an impor-
tant point that has not been widely appreciated before.
Furthermore, the mode of injury and the time of injury
are different compared with that caused by the embolic
ischemic insult, which is also new information.
Finally, it is critically important not only to focus on
removing emboli and cerebral hemodynamics and oxygen
consumption but also to assess some indicator of func-
tional neurologic recovery and the pathologic extent of
cerebral injury. Otherwise, your results in this experiment
could have been interpreted entirely differently. The
bottom line is that we have to refine how to use RCP if we
are going to continue to use it to maximal patient advan-
tage.
I am concerned about the relevance of this porcine
model to man, because much work has been done previ-
ously in subhuman primates and other species. Can you
tell us if you and your colleagues expect that these
observations will apply to man as well as they do to the
pig, given the anatomic and physiologic differences be-
tween species?
Dr. Juvonen. First, I would like to thank Dr. Miller for
his kind remarks regarding our paper. We acknowledge
that there are several problems in using animal models
overall. If we specifically look at cerebral perfusion, we
have to have a model in which it is feasible carry out RCP.
In this respect, the dog model, which is used frequently in
cardiac surgery, failed because there exist competent
jugular valves; it is more complicated to create RCP
beyond jugular veins. Although there are many papers in
the literature with a dog model, this was the reason we
selected a porcine model for RCP studies. We have found
that the rate of competent jugular valves in pigs is
approximately 20%. In this subgroup of animals, there is
a distinct gradient between SVC and sagittal sinus pres-
sures at least at the beginning of the experiment. The
human cadaver study by de Brux and colleagues13 indi-
cated that there are competent jugular valves in 85% of
human beings and that the azygos vein system is the major
pathway to the central nervous system. This finding was
also present in an RCP study performed on nonhuman
primates, baboon monkeys by Boeckxstaens and Fla-
meng,16 indicating that less than 1% of blood returned to
the aortic arch during retrograde perfusion and more than
90% was circulating and shunting to the IVC. Our point is
that there should be little doubt that ,during RCP without
IVC occlusion, the high-capacity and low-resistance de-
scending venous bed will drain most of RCP volume
regardless of whether the jugular veins are valvulated or
not.
It is also important to notice that we monitored sagittal
sinus pressure and maintained it at 25 mm Hg during the
protocol and assumed that the sagittal sinus pathway is at
least a significant pathway for retrograde perfusion in the
pig. In this respect, this material is homogeneous; all
animals were subject to the same pressure during retro-
grade perfusion. And we found that effective blood flow
return to the aortic arch was much lower in RCP when the
IVC was opened supporting the presence of a shunt.
Moreover, we would like to emphasize that the major
interest in our current study was RCP-O, and that all our
major findings and conclusions concerned the IVC occlu-
sion method. We feel strongly that the existence of valves
and differences between species is less important if we
want to pressurize an entire venous system. Actually we
have data showing how SVC, IVC, and sagittal sinus
pressures equalize during RCP in animals after the vas-
cular bed is filled.
Dr. Miller. Are you saying that the pig is the best model
short of a human?
Dr. Juvonen. I believe that it is a relevant model and
one of the best so far.
Dr. Miller. My second question is about these polysty-
rene microspheres. They are very small; they are very
light, and they are certainly not atheromatous or throm-
botic debris, which have more mass. How much do these
differences limit the interpretation of your results when
we go back home to the operating room?
Dr. Juvonen. We admit that albumin-coated micro-
spheres 250 to 750 mm in diameter are very different from
atheroma debris, but the finding that we were able to
generate effective RCP flow to wash out microspheres
from the deep brain suggests that this could be a potent
method to wash out larger particles from extracranial
arteries as well. In this context, I would like to review our
current clinical experience at Mount Sinai Hospital. Re-
sults of this kind from our experimental laboratory have
modified our clinical RCP protocol in a way that we are
using RCP when the IVC is occluded only in cases in
which a loose clot or atheromatous debris is present
during aortic surgery, and the central venous pressure is
kept below 20 mm Hg. After adopting this RCP protocol
for clinical use, the incidence of strokes has decreased, but
the observation is that these patients wake up more slowly
and are extubated later than those who have undergone
HCA alone. This is in line with our experimental findings.
Dr. Miller. That leads to my wrap-up statement. We
must remember that Dr. Griepp’s group has shown clini-
cally in a multivariate analysis that RCP is actually a
predictor of stroke during aortic arch procedures in their
experience, mainly because they only use it when there is
a lot of debris in the arch, that is, in patients at relatively
high risk of stroke. So, as I understand your conclusions,
clinically you are now advocating RCP with low pressure
and with IVC occlusion in selected patients. Are you using
RCP for a brief period of time or throughout the entire
circulatory arrest interval?
Dr. Juvonen. It is used either for a brief period of time
or intermittently.
Dr. Miller. So you advise that we limit the time duration
of RCP and keep the pressure low to try to minimize the
cerebral edema?
Dr. Juvonen. Yes I recommend, if an entire venous
vascular bed is pressurized.
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